AU2007264975A1 - Formulations with feruloyl glycerides and methods of preparation - Google Patents

Formulations with feruloyl glycerides and methods of preparation Download PDF

Info

Publication number
AU2007264975A1
AU2007264975A1 AU2007264975A AU2007264975A AU2007264975A1 AU 2007264975 A1 AU2007264975 A1 AU 2007264975A1 AU 2007264975 A AU2007264975 A AU 2007264975A AU 2007264975 A AU2007264975 A AU 2007264975A AU 2007264975 A1 AU2007264975 A1 AU 2007264975A1
Authority
AU
Australia
Prior art keywords
product
topical application
feruloyl
acid
different
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007264975A
Inventor
David L. Compton
Louis J. Defilippi
Steven G. Grall
James F. Kinney
Joseph A. Laszlo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotech Research and Development Corp
Original Assignee
Biotech Research and Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Research and Development Corp filed Critical Biotech Research and Development Corp
Publication of AU2007264975A1 publication Critical patent/AU2007264975A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216Solid or semisolid forms
    • A61K8/0229Sticks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00Formulations or additives for perfume preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/001Preparations for care of the lips
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/12Preparations containing hair conditioners
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q9/00Preparations for removing hair or for aiding hair removal
    • A61Q9/02Shaving preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/004Preparations used to protect coloured hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Description

WO 2008/003090 PCT/US2007/072557 1 FORMULATIONS WITH FERULOYL GLYCERIDES AND METHODS OF PREPARATION CROSS-REFERENCE TO RELATED APPLICATIONS [01] This application claims priority to U.S. Provisional Application No. 60/817,537, filed on June 29, 2006, and entitled "Formulations with Feruloyl Glycerides and Methods of Preparation, which is hereby incorporated herein by reference in its entirety. FIELD OF THE INVENTION [02] The present invention relates to feruloyl glycerides, their method of preparation, and their use in personal care consumer product applications. BACKGROUND OF THE INVENTION [03] Feruloyl-substituted and coumaryl-substituted acylglycerols, their method of preparation through the transesterfication of a triglyceride and a ferulic or coumaric ester, and the use of these compounds as sunscreen ingredients is taught in U.S. Patent No. 6,346,236, which incorporated herein by reference in its entirety. SUMMARY OF THE INVENTION [04] Feruloyl glycerides have been discovered and are the subject matter of pending patent applications. See U.S. Provisional Application Serial No. 60/723,209, filed October 3, 2005 and entitled "Accelerated Feruloylation of Vegetable Oils," which is incorporated herein by reference, and U.S. Patent Application Serial No. 11/425,094, [Atty. Docket No. 1396-00601], filed June 19, 2006, and entitled "Compositions Comprising A UV Absorbing Chromophore," and U.S. Patent Application Serial No. 11/425,096, [Atty. Docket No. 1396-00602], filed June 19, 2006, and entitled "Methods of Making Compositions Comprising A UV-Absorbing Chromophore," all of which are incorporated by reference herein in their entireties. [05] It has been discovered that these compounds provide a springboard into a broad spectrum of formulating applications within the personal care and over-the-counter (OTC) product categories. Unlike traditional ingredients, the feruloyl glycerides of the WO 2008/003090 PCT/US2007/072557 2 present invention have multi-functional properties, and as a result provide a multitude of unexpected benefits and superior characteristics to skin, hair, bath, dental and OTC products. [06] Disclosed herein products for topical application comprising a chemical composition comprising a linker agent and a compound comprising at least one UV-absorbing chromophore, wherein the linker agent is characterized by the general formula: HCa-Cb-Cc-(Y)d-Ce-Cf -H X1H., X2Hn2 wherein X 1 and X 2 are the same or different, and at least one of X 1 or X 2 is a functional group that bonds with the compound comprising at least one UV-absorbing chromophore, and b+f > 2, Y comprises an O, N, or S that is substituted or unsubstituted, each a, b, c, e and f is > 0 and a+b+c+e+f >2, d is 0 or 1, nl and n2 represent the number of hydrogen atoms required to complete the undesignated valencies, and m ranges from 1 to about 100 and each individual m unit may be the same or different, and a topically acceptable agent that is different from the linker agent and the compound comprising at least one UV-absorbing chromophore. [07] Also disclosed herein are products for topical application comprising formulations comprising a fat soluble composition comprising a mono or diacylglycerol esterified with a plant-derived functional group comprising an aromatic species, an unsaturated isoprenoid, an unsaturated terpenoid, a hindered hydroxy-substituted cinnamic acid, an unhindered hydroxy-substituted cinnamic acid or combinations thereof, and a topically acceptable agent that is different from the fat soluble composition. [08] Also disclosed herein are products for topical application comprising formulations comprising a fat-soluble composition, comprising a glycerol esterified with a plant derived functional group comprising maleanilic acid, homovanillic acid, folic acid, crocetin, coumaric acid, caffeic acid, ferulic acid, sinapic acid (sinapinic acid), derivatives thereof or combinations thereof, wherein the esterified glycerol includes at WO 2008/003090 PCT/US2007/072557 3 least two plant-derived functional groups, and a topically acceptable agent that is different from fat-soluble composition. [09] Also disclosed herein products for topical application comprising formulations comprising a chemical composition comprising a linker agent and a compound comprising at least one UV absorbing chromophore, wherein the linker agent is characterized by the general formula: X3 X4 H -Ca- Cb-Cc-(Y)d-Ce-Cf-H X1H., X2Hn2 wherein X 1 and X 2 are the same or different at least one of X, or X 2 is a functional group that bonds with the compound comprising at least one UV-absorbing chromophore, and b+f > 2, X 3 and X 4 are the same or different and X 3 , X 4 or both is a hydrophobic moiety, Y comprises an O, N, or S that is substituted or unsubstituted, each a, b, c, e and f is > 0 and a+b+c+e+f 2, d is 0 or 1, nl and n2 represent the number of hydrogen atoms required to complete the undesignated valencies, and m ranges from 1 to about 100 and each individual m unit may be the same or different, and a topically acceptable agent that is different from the linker agent and the compound comprising at least one UV-absorbing chromophore. [10] Also disclosed herein are products for topical application comprising formulations comprising a chemical composition comprising at least two compounds having the general formula: X3 X4 H -Ca- b-Cc-(Y)d-Ce-Cf-H X1Hnj X2Hn2 WO 2008/003090 PCT/US2007/072557 4 wherein Xi and X 2 are different at least one of X, or X 2 is a functional group that bonds with a compound comprising at least one UV-absorbing chromophore, and b+f > 2, X 3 and X 4 are the same or different and X 3 , X 4 or both is a hydrophobic moiety, Y comprises an O, N, or S that is substituted or unsubstituted, each a, b, c, e and f is > 0 and a+b+c+e+f >2, d is 0 or 1, nl and n2 represent the number of hydrogen atoms required to complete the undesignated valencies, m ranges from 1 to about 100 and each individual m unit may be the same or different, and wherein the compound comprising at least one UV-absorbing chromophore comprises a phytochemical which further comprises an aromatic species, an unsaturated isoprenoid, an unsaturated terpenoid, a hindered hydroxy-substituted cinnamic acid, an unhindered hydroxy-substituted cinnamic acid or combinations thereof, and a topically acceptable agent that is different from the chemical composition comprising at least two compounds. [11] The foregoing has outlined rather broadly the features and technical advantages of the present invention in order that the detailed description of the invention that follows may be better understood. Additional features and advantages of the invention will be described hereinafter that form the subject of the claims of the invention. It should be appreciated by those skilled in the art that the conception and the specific embodiments disclosed may be readily utilized as a basis for modifying or designing other structures for carrying out the same purposes of the present invention. It should also be realized by those skilled in the art that such equivalent constructions do not depart from the spirit and scope of the invention as set forth in the appended claims. DETAILED DESCRIPTION OF EMBODIMENTS [12] The formulations of the present invention comprise compounds that are described in U.S. Patent Application Serial No. 11/425,094, [Atty. Docket No. 1396-00601], filed June 19, 2006, and entitled "Compositions Comprising A UV-Absorbing Chromophore," and U.S. Patent Application Serial No. 11/425,096, [Atty. Docket No. 1396-00602], filed June 19, 2006, and entitled "Methods of Making Compositions Comprising A UV-Absorbing Chromophore," both of which are incorporated by reference herein in their entireties.
WO 2008/003090 PCT/US2007/072557 5 [13] Described below are several product applications for formulations in accordance with the present invention. Each application has been made and tested in blind coded consumer panel samples. These tests demonstrate superior aesthetic and consumer product characteristics arising from the compounds of the present invention. The product applications for using the feruloyl glycerides in the present invention are not limited to examples cited herein. Rather, these examples are evidence of the unique multi-functional benefits that are provided with the use of these naturally derived mono, di and triglycerides. [14] Before offering detailed formula examples of product applications wherein superior consumer benefits have been realized through the use of feruloyl glycerides, it is worth a few sentences to review the multi-functional attributes that this material has exhibited. [15] The feruloyl glycerides used in accordance with the present invention are lipophilic in nature, with a unique fingerprint of saturated and unsaturated esterified fatty acids, feruloyl esters and hydroxyl groups. As such, the feruloyl glycerides of the present invention are miscible with many other oil-like substances, have a high kb (kauri butanol) value and solvent power, and have excellent skin and hair absorption and/or penetration characteristics. The feruloyl glycerides of the present invention provide the skin with superior moisture barrier properties, add light reflective or radiance characteristics to dull, dry skin, absorb both Ultra Violet A and B wavelengths of sunlight, offer the skin superior antioxidant protection at various levels within the epidermis, and improve the emollient and dry feel characteristics of the skin. The feruloyl glycerides of the present invention protect colored hair from sun bleaching (i.e. elimination of the color producing chromophore in oxidized dye, such as paraphenylenediamine, plus peroxide), and add conditioning benefits and light reflection to hair. The feruloyl glycerides also help prevent the photodamage that causes all hair types to develop undersirable combing properties after UV exposure. This damage is frequently observed in the cuticle (outer skin of hair fiber) of the hair fiber. The prevention of photodamage to gray hair swatches can be observed in combing force of treated and control hair tresses, contact angle measurements, and preserving tryptophan, a key amino acid that decomposes on exposure to UV radiation. The feruloyl glycerides of the present invention protect lips, skin and hair against WO 2008/003090 PCT/US2007/072557 6 environmental damage, and create a synergistic effect with many other cosmetic and over-the-counter ("OTC") ingredients. [16] In the above paragraph, we indicated that the feruloyl glycerides have excellent solvent characteristics. This solvency is shown in the following phospholipid vitamin complex lotions. 1) A clear solution of 10% cholesterol powder in 90% feruloyl soy glyceride, 2) A set of clear solutions of 10% Vitamins E, A, D3, F (gamma linolenic acid) and 90% feruloyl soy glycerides 3) A set of clear solutions comprising 10% Uniqema's "Arlasilk M Phospholipid EFA [ Linoleamidopropyl PG-Dimonium Chloride Phosphate] and 90% feruloyl soy glycerides, 4) A series of solutions containing OTC sunscreens Avobenzone (3%), Benzophenone (5%), Octyl salicylate (4%), Octyl methoxycinnamate (7.5%), Octocrylene (10%) and q.s (quotient sufficient to make 100%) with feruloyl soy glycerides. All solutions remained stable for more than 3 months at 75F. [171 Manufacturing Procedure: (for all of the formulations listed below) [181 In general, add Phase A components to main batch tank. Mix using a high shear mixer (e.g. a Lightning Mixer No. 4). Sprinkle thickener (if any) into vortex, created by a mixer. Mix until particles are dissolved or dispersed, while heating to 55 0 C. The feruloyl glyceride in the following examples comprised a family of feruloyl glycerides made from soy. It will be recognized that any feruloyl glyceride derived from any source or in any manner is encompassed within this invention. Feruloyl glyceride can be added to the oil phase ingredients in phase B, in a suitably sized premix vessel, heated and/or mixed until dissolved and/or dispersed, and then added to the main batch (phase A) with mixing. [191 Heat Phase B to 55 0 C, with mixing. When particles are dissolved, add Phase B to Phase A with vigorous mixing. [201 Turn on slow sweep and cool batch to 40 0 C, add other Phases. [211 Sample to Quality Control for review and approval at 25 0
C.
WO 2008/003090 PCT/US2007/072557 7 [22] Feruloyl glyceride is an oil based component and has an oily feel at room temperature. Feruloyl glyceride is not water soluble, and it can act as a solvent for ingredients that are difficult to dissolve in water. In some embodiments, it may be desirable to suspend feruloyl glyceride withn a matrix of emulsion or gel. In some embodiments, it may be desirable to obtain an emulsion comprising feruloyl glyceride using a suitable emulsifier. In some embodiments, it may be desirable to incorporate such an emulsion in a final product that has a desired viscosity, and to achieve such a desired viscosity, a suitable viscosity modifier may be used. An emulsifier and/or viscosity modifier and/or surfactant can be a topically acceptable agent that is different from the linker agent or the compound comprising at least one UV-absorbing chromophore. [23] The pH of the final product comprising feruloyl glyceride can be any acceptable pH that is compatible with the purpose of the final product. For example, but not by way of limitation, when the final product is to be applied to the skin or hair, the pH range can be about 2.5 to about 9.0. For example, but not by way of limitation, when the final product is a shampoo, the pH range can be about 6.0 to about 8.0. For example, but not by way of limitation, when the final product is a moisture skin care product, the pH range can be about 4.0 to about 6.0. For example, but not by way of limitation, when the final product is an exfoliant and/or hair conditioner, the pH range can be about 2.0 to about 4.0. The final product can be hypoallergenic. [24] Example 1 [25] Phospholipid Vitamin Complex Lotion [26] Phase Wt. % Ingredient A 69.5 Water A 2.0 Hydroxyethylcellulose (a viscosity modifier) A 5.0 Glycerin (a skin emollient) A 2.8 Ascorbic Acid (Vitamin C) (an antioxidant) A 0.1 Phytonadione (Vitamin K) (an antioxidant) A 0.1 Biotin (Vitamin B7) (an antioxidant) B 3.0 Stearyl Alcohol (a stabilizer and for thickening the oil phase) B 2.0 Glyceryl Stearate (a stabilizer and for thickening the oil phase) WO 2008/003090 PCT/US2007/072557 8 B 0.5 Squalane (a skin emollient) B 0.5 Olive Oil Amidopropyl Phosphatidyl PG-Dimonium Chloride (an emulsifier, also comprising what issometimes called an essential fatty acid ("EFA") of a phospholipid B 3.0 Tocopherol Acetate (Vitamin E) B 0.5 Retinyl Palmitate (Vitamin A) B 0.5 Cholecaliferol (Vitamin D3 ) B 0.5 Linoleic Acid (Vitamin F) B 2.0 PEG-40 Stearate (an emulsifier) B 5.0 Feruloyl Glyceride B 0.1 Ubiquinone 50 (Coenzyme Q10) (an antioxidant) B 1.0 Cyclomethicone (a smoothing agent and a component that provides water resistance so final product does not undesirably wash off skin easily) B 0.9 Steareth-20 (an emulsifier) C 0.2 Fragrance D 0.3 Water D 0.3 Phenoxyethanol (a preservative) D 0.2 Methylparaben (a preservative) 100.00 [27] It is well known that certain vitamins and amino acids are referred to as "essential" in nutritional products, since the body does not make these materials and one must include them in one's diet. In topically applied products they are equally important. Both Vitamin E and C are well known for their antioxidant properties within the skin and also for the fact that they work together in maintaining a natural defense against radicals. There is a significant amount of scientific evidence that the combination of Vitamin E and C significantly reduced the sunburn reaction to UVb irradiation. There is also evidence of the benefit of applying Vitamin D3 to the skin. The feruloyl glycerides of the present invention are excellent solvents for cholesterol and its derivatives which are excellent skin conditioning agents. Vitamin D3 is easily solubilized as well as other antioxidants, such as Coenzyme Q-10 [ubiquinone] or Superoxide Dismutase. If desired, a chelating agent, e.g., ethylenediamine tetraacetic acid ("EDTA"), can be added in the above example, and a corresponding amount of water can be reduced if a chelating agent (often in solution) is added.
WO 2008/003090 PCT/US2007/072557 9 [28] In pre-sun and post-sun applications during a weekend, panelists treating one arm with the cream described above and a second arm with a similar control cream without the feruloyl glycerides of the present invention. When compared side by side, the arms treated with the feruloyl glycerides of the present invention had far less sunburn and blistering versus the control arm. All panelists verified that they had spent a minimum of 4 total hours in the sun on Saturday and Sunday. [29] In the above example, it is estimated that the SPF in the control was about 2-4, and that the SPF of the product containing feruloyl glycerides in accordance with the invention was about 7-10. [30] Example 2 [31] Water Resistant Sunscreen with Feruloyl Glycerides [32] Phase Wt. % Ingredient A 51.40 Deionized Water A 1.50 Butylene Glycol (an emollient) A 0.20 Carbomer 940 (a visocity modifier) B 7.50 Octinoxate (a sunscreen) B 6.00 Oxybenzone (a sunscreen) B 5.00 Octisalate (a sunscreen) B 10.00 Octocrylene (a sunscreen) B 8.00 Feruloyl Glyceride B 1.50 PEG 40 Stearate (an emulsifier) B 0.50 Steareth 20 (an emulsifier) C 5.00 Deionized Water C 0.30 Triethanolamine (a component that acts to neutralize Carbomer 940) D 2.00 Acrylates/C12-22 Alkylmethacrylate Copolymer (a component that provides water resistance so final product does not undesirably wash off skin easily) E 0.60 Propylene Glycol and/or lodopropynyl Butylcarbamate (Liquid Germal Plus) (preservataives) E 0.50 Phenoxyethanol and/or WO 2008/003090 PCT/US2007/072557 10 Isobutylparaben and/or Isopropylparaben and/or Butylparaben (Liquapar Optima) (preservatives) [33] The feruloyl glycerides of the present invention are especially well suited to solubilizing sunscreens. Many of these sunscreen ingredients are known to form a powder after skin application as an emulsion and drying. This crystal formation causes a loss in UVb protection as the sunscreens simply flake off after drying. The presence of feruloyl glycerides solubilize all oil soluble sunscreens and create a low melting eutectic which insures that the sunscreens remain fluid, are absorbed into the skin and will not powder on dry down. This provides products with longer lasting sun protection. [34] In side-by-side comparison testing, the formulation containing feruloyl glycerides provided longer lasting sun protection than the same formulation that did not contain feruloyl glycerides. [35] Example 3 [36] Lasting Color Hair Conditioner with Feruloyl Glycerides [37] Phase Wt.% Ingredient A 80.0 Deionized Water A 0.5 Carbomer 940 (a viscosity modifier) B 0.2 Isostearamidopropyl Ethydimonium Ethosulfate (a hair conditioner B 0.3 Soyamidopropyl Ehydimonium Ethosulfate (a hair conditioner) B 3.0 Feruloyl Glycerides B 2.0 Polyquaternium 11 (a hair conditioner) B 1.5 PEG 100 Stearate (an emulsifier) B 1.0 Self Emulsifying Glyceryl MonoStearate (an emulsifier) C 0.7 Triethanolamine a component that acts to neutralize Carbomer 940) C 10.0 Deionized Water C 0.5 Imidazolidinyl Urea (a preservative) [38] The feruloyl glycerides of the present invention add excellent conditioning properties to hair conditioner formulations. They are readily absorbed into porous hair which has been treated with chemical services (hair coloring, bleaching, permanent waves, WO 2008/003090 PCT/US2007/072557 11 straightening, etc.). After dry down, the hair exhibits excellent shine and luster, manageability and feels silky smooth. The feruloyl glycerides of the present invention are excellent additives for enhancing the long lasting hair colors that are perceived in permanent dyes. They do this by protecting the synthetic hair color from air oxidation and absorb both UVa and UVb ultraviolet rays which damage the color and eliminate the color producing chromophore. [39] In one test, hair swatches were colored with one of two commercially available permanent hair coloring products for medium ash brown. Some hair swatches were then wrapped in foil, while other hair swatches were either treated with a conditioner that contained feruloyl glycerides in accordance with the above formulation, or a control formulation that did not contain feruloyl glycerides. The non-foiled hair swatches were then exposed to northern sunlight for 32 hours and then compared to the hair swatches that had been foiled. The hair swatches that had been treated with a conditioner that contained feruloyl glycerides in accordance with the above formulation were much closer in color to the foiled hair swatches than the control formulation that did not contain feruloyl glycerides. [40] Example 4 [41] Lip Protector/Lip Stick [42] Phase Wt. % Ingredient A 49 Castor Oil (a diluent) A 10 Feruloyl Glycerides A 8 Beeswax (a wax component to build stick structure) A 4 Carnauba Wax (a wax component to build stick structure) A 5 Candelilla Wax(a wax component to build stick structure) A 1 Ozokerite Wax(a wax component to build stick structure) A 10 Isopropyl Myristate (an emollient) A 5 Dimethicone (a silicone to provide shine) A 8 Color Grind of Pigments and Castor Oil (an optional component if color is desired) [43] A major site of sun damage and premature aging is the lip area. The feruloyl glycerides of the present invention show excellent compatibility with lipstick ingredients and WO 2008/003090 PCT/US2007/072557 12 provide emolliency, absorption, environmental protection (sun and wind damage), and prevention of transdermal moisture loss. [44] In one test, lips were treated with feruloyl glycerides in accordance with the above formulation, and separately treated at a different time with a control formulation that did not contain feruloyl glycerides. Lips that had been treated with feruloyl glycerides in accordance with the above formulation felt better than lips that had been treated with the control formulation that did not contain feruloyl glycerides. [45] Example 5 [46] Extra Moisturizing, Anti-Aging Shave Cream [47] Phase Wt. % Ingredient A 6.00 Stearic Acid (for soap formation in combination with Triethanolamine) A 1.00 Coconut Acid (for soap formation in combination with Triethanolamine) A 1.00 Lauryeth 4 (an emulsifier) A 2.00 Mineral Oil (an emollient) A 4.00 Feruloyl Glycerides A 3.00 Isostearyl Neopentanoate (an emollient) B 60.0 Demineralized Water B 5.0 Glycerin (an emollient) B 8.0 Ammonium Lauryl Sulfate (a surfactant) B 2.0 Cocamidopropyl Betaine (a surfactant) B 2.0 Acrylates/Octylacrylamide Copolymer (a viscosity modifier) B 4.8 Triethanolamine (neutralizes stearic acid and coconut acid and for forms a soap with each) C 1.0 Propylene Glycol and/or Methylparaben and/or Propylparaben (preservatives) D 0.2 Fragrance 100 [48] Some skin specialists have viewed daily shaving as an exercise in daily exfoliation of the skin. When looked at shaving in this manner, one is not only removing the daily beard, but is also eliminating much of the stratum corneum cells on the skin's surface.
WO 2008/003090 PCT/US2007/072557 13 This exposes the new skin surface to unprotected UVb and UVa exposure everyday after shaving. The presence of feruloyl glycerides of the present invention in a shaving preparation insures some skin absorption of this powerful antioxidant at the beginning of each day, thereby reducing environmental damage to the skin. [49] Panelists preferred the above shaving formulation containing feruloyl glycerides over a shaving control formulation that did not contain feruloyl glycerides. [50] Example 6 [51] Skin Lightener Formulations [52] The feruloyl glycerides of the present invention may be used in skin lightener formulations that carry other active ingredients into the epidermis and thus slow the melanin formation process in age spots. A formulation can be prepared using the formulation of Example 2, adding 1.5% Kojic acid, and reducing the amount of water a corresponding amount, i.e., reduce the amount of water by 1.5%. Kojic acid can be part of Phase B. Kojic acid can penetrate the epidermis and help reduce the production of melanin. [53] In one test, a formulation containing feruloyl glycerides was applied to one area of skin having age spots, and a control formulation not containing feruloyl glycerides was applied to another area of skin having age spots. Panelists preferred the formulation containing feruloyl glycerides over the control formulation. Viewing the skin areas after 28 days, 56 days and 84 days showed that skin areas treated with the formulation containing feruloyl glycerides were lighter in color than the skin areas that had been treated with the control formulation. [54] Example 7 [55] Anti-Aging Stick Protector [56] The feruloyl glycerides of the present invention may be incorporated into an anti-aging stick protector to carry peptides into the skin, calling for maximum production of collagen and elastin proteins and minimizing premature degradation of these skin tightening support proteins. Anti-Aging formulations may protect the skin from UVa WO 2008/003090 PCT/US2007/072557 14 irradiation from normal sunlight, may alter the skin's moisture retentive characteristics, may add to the skin luminescence, may prevent the excess formation of melanin containing age spots, and may prevent the formation of radicals from UVb and UVa, which then react with other skin ingredients to alter its natural flexibility and tightness. The manufacturing process can involve addition of the liquids to the main batch kettle with mixing. Heat from a jacket kettle can be turned on and the solid ingredients can be added one at a time, until the complete system is melted and solubilized and/or fully dispersed. The hot liquid can then poured in suitable stick molds and allowed to cool and solidify. Anti-Aging Stick Phase % Ingredient A 40.25% Castor oil (a diluent) A 20% Feruloyl Soy Glycerides A 10% Isopropyl Myristate (an emulsifier) A 9.0 Octycrylene (a sunscreen) A 3.0 Avobenzone (a sunscreen) A 7.0 Octyl methoxycinnamate (a sunscreen) A 5.0 Candelilla Wax (a was to build a stick structure) A 1.0 Carnauba Wax (a was to build a stick structure) A 0.75 Ozokerite Wax (a was to build a stick structure) A 4.0 Beezwax (a was to build a stick structure) 100% [57] Panelists preferred the formulation containing feruloyl glycerides over a control formulation that did not contain feruloyl glycerides. This product is particularly useful WO 2008/003090 PCT/US2007/072557 15 to protect skin around the eyes, the skin of the nose, and other portions of the face from sunlight. [58] Example 8 [59] Dental Cleanser [60] The feruloyl glycerides of the present invention may be incorporated into a dental cleanser to solubilize dental stains and to flush them away, for example, as part of a dental paste or mouthwash. Dental Gel Phase % Ingredients A 1.0 Carboxymethyl cellulose (a thickener) A 3.0 Feruloyl Soy Glycerides A 60 Sorbitol (a diluent and sweetener) A 11.4 Water A 5 Sodium Saccahrin (a sweetener) A 8 Sodium Silicate (a thickener) A 10 Sodium Silicate (an abrasive, with larger particles than the sodium silicate used as a thickener) A 1.0 Flavor A 0.6 Sodium Lauryl Sulfate (dental grade cleanser, .e.g, a dental grade cleanser without a soapy taste) WO 2008/003090 PCT/US2007/072557 16 [61] Panelists preferred the formulation containing feruloyl glycerides over a control formulation that did not contain feruloyl glycerides. [62] Example 9 [63] Co-Solvent for Fragrances [64] The feruloyl glycerides of the present invention may be used as co-solvent in fragrance compounding. When creating fragrances, perfumers draw on thousands of scented and fixing compounds which complex with other ingredients within the perfume formulation to achieve the ultimate fragrance interpretation that is desired. The science of perfumery is thousands of years old and normally requires an apprenticeship of 5 years or more with a Master Perfumer to receive accreditation by the American Society of Perfumers. The basic construction of fragrances includes 3 divisions within the fragrance. These are referred to as top, middle and bottom notes. The top notes are light, delicate and quickly volatize at room temperature. The middle notes have more body and require more heat and energy to lift from the skin. The bottom notes of a fragrance form its foundation. They are the heavy lasting notes. Holding the top, middle and bottom notes together involves the science of fixatives. A well-balanced fragrance normally presents itself as a well-balanced bouquet with strong foundation notes, middle statements and sparkles of unexpected top notes. While this is generally true, the opposite is often an unexpected pleasure as in the classic ChannelTM No. 5 fragrance, which is mostly sparkling top notes, with moderate to slight base notes. [65] Within every fragrance the choice of solvent (or several co-solvents) often plays a critical role in the fragrances stability, application characteristics and lasting power. Typical fragrance ingredients (remember there are thousands to choose from) include terpineol, linalool, benzyl alcohol, benzaldehyde, ylang-ylang and so on. To hold all of these 25-100 ingredients together in a stable solution is no small task. Many times the perfumer feels that they have a stable solution but then there is a formation of one crystal, then another and quickly an avalanche of components falling from what was a clear solution. [66] Diethyl phthalate (DEP), Dioctyl adipate (DOA), and Propylene Glycol are three of the most common solvents used in perfumery by perfumers. The feruloyl glycerides of the WO 2008/003090 PCT/US2007/072557 17 present invention bring a totally new dimension to the science of perfumery. It is a useful solvent that takes a broad variety of hydrophobic and some slightly hydrophilic materials into solution. The feruloyl glycerides of the present invention have shown possibilities of forming clathrate structures around fragrances and individual components, which will enhance their stability, performance and resistance to attack. Being a partial triglyceride, fatty acid ester and ferulic acid ester we see an unexpected synergy of solvent properties, antioxidant characteristics, UVa & b absorbance qualities, skin absorption characteristics, surface activity, and addition to structural type delivery. Fragrances can be made into alcohol solutions, gels, solids, etc. They can be positioned as providing health benefits, anti-aging benefits, environmental protectants, sun protection fragrances as well as many other characteristics. With some hydroxyl substitution and/or ethoxylation on the triglyceride moieties, the molecule can solubilize and/or emulsify hydrophilic materials. [67] Panelists found that the formulation containing feruloyl glycerides performed just as well in terms of fragrance stability, application characteristics and lasting power as a control formulation that contained DEP instead of feruloyl glycerides. And, a formulation containing DEP does not provide the same UV protection and anti-aging attributes as a formulation containing feruloyl glycerides. [68] In accordance with the invention the amount of feruloyl glyceride (which is a combination of a linker agent and a compound comprising at least one UV-absorbing chromophore) in a product for topical application as described above can be any suitable range, but is typically about 10% by weight or less of the product. In one preferred embodiment, the amount of the combination of a linker agent and a compound comprising at least one UV-absorbing chromophore in a product for topical application is in the range of about 3% to 10% by weight. For a phospholipid vitamin complex lotion, the amount of a combination of a linker agent and a compound comprising at least one UV-absorbing chromophore is preferably about 5% by weight. For a water resistant sunscreen, the amount of a linker agent and a compound comprising at least one UV-absorbing chromophore is preferably about 8% by weight. For a hair conditioner, the amount of a combination of a linker agent and a compound comprising at least one UV-absorbing chromophore is preferably about 3% by weight. For a lip WO 2008/003090 PCT/US2007/072557 18 protector and/or lip stick, the amount of a combination of a linker agent and a compound comprising at least one UV-absorbing chromophore is preferably about 10% by weight. For a shave cream, the amount of a combination of a linker agent and a compound comprising at least one UV-absorbing chromophore is preferably about 4% by weight. In each event the resultant combination incorporates topically acceptable agents other than the linker agent/chromophore such as for feruloyl glyceride in an amount of about 90% by weight or more. The resultant combination comprises a synergistic mixture which is favored and efficacious relative to mixtures which are absent the linker agent/chromophore combination (e.g., feruloyl glyceride). [69] The embodiments of the invention, and the invention itself, are now described in such full, clear, concise and exact terms to enable a person of ordinary skill in the art to make and use the invention. To particularly point out and distinctly claim the subject matters regarded as invention, the following claims conclude this specification. To the extent variations from the preferred embodiments fall within the limits of the claims, they are considered to be part of the invention, and claimed.

Claims (66)

1. A product for topical application comprising a chemical composition comprising in combination a linker agent and a compound comprising at least one UV-absorbing chromophore, wherein the linker agent is characterized by the general formula: H-Ca-Cb-Cc-(Y)d-Ce-f -H X1Hnl X 2 Hn 2 wherein: X 1 and X 2 are the same or different, and at least one of Xi or X 2 is a functional group that bonds with the compound comprising at least one UV-absorbing chromophore, and b+f > 2; Y comprises an O, N, or S that is substituted or unsubstituted; each a, b, c, e and f is > 0 and a+b+c+e+f >2; d is 0 or 1; n1 and n2 represent the number of hydrogen atoms required to complete the undesignated valencies; and m ranges from 1 to about 100 and each individual m unit may be the same or different, and a topically acceptable agent that is different from the linker agent and the compound comprising at least one UV-absorbing chromophore.
2. The product for topical application of claim 1 wherein the compound comprising at least one UV-absorbing chromophore comprises a phytochemical.
3. The product for topical application of claim 1 wherein each Xi, or X 2 , when present, comprises O, N, or S.
4. The product for topical application of claim 1 wherein the linker agent further comprises a terminal carbon atom, Cg, adjacent Cf, and g > 1.
5. The product for topical application of claim 1 wherein substituents on one or more Y units, C units or both form cyclic substituents. WO 2008/003090 PCT/US2007/072557 20
6. The product for topical application of claim 5 wherein the cyclic substituents do not comprise an acetal or hemiacetal.
7. The product for topical application of claim 1 wherein b > 3 and further comprising a second compound comprising at least one UV-absorbing chromophore wherein the first and second compounds comprising at least one UV-absorbing chromophore are the same or different.
8. The product for topical application of claim 7 wherein the first, the second or both compounds comprising at least one UV-absorbing chromophore further comprise a phytochemical.
9. The product for topical application of claim 7 wherein Xl, X2 or both are capable of bonding with the phytochemical.
10. The product for topical application of claim 1 wherein Xi and X 2 when present, are selected such that the linker agent comprises a polyvinyl alcohol, an amine, a diol, a triol, a thiol or combinations thereof
11. The product for topical application of claim 10 wherein the linker agent comprises ethylene glycol, ethylenediamine, 1,2-propylene glycol, 1,3 propylene glycol, glycerol, 2-mercaptoethanol, 2-ethanolamine, 1,4-butanediol, diethylene glycol, or combinations thereof
12. The product for topical application of claim 1 wherein the linker agent is derived by chemical modification of a triacylglycerol.
13. The product for topical application of claim 12 wherein the triacylglycerol comprises a vegetable oil.
14. The product for topical application of claim 12 wherein the triacylglycerol is a vegetable oil comprising soybean oil, corn oil, sunflower seed oil, high-oleic sunflower seed oil, canola oil, safflower oil, cuphea oil, coconut oil, olive oil, palm kernel oil or combinations thereof
15. The product for topical application of claim 12 wherein chemical modification of the triacylglycerol comprises enzymatic treatment.
16. The product for topical application of claim 15 wherein enzymatic treatment comprises incubation with a esterase. WO 2008/003090 PCT/US2007/072557 21
17. The product for topical application of claim 2 wherein the phytochemical comprises any carboxyl containing phytochemical.
18 The product for topical application of claim 17 wherein the phytochemical comprises an aromatic species, an unsaturated isoprenoid, an unsaturated terpenoid, a hindered hydroxy-substituted cinnamic acid, an unhindered hydroxy-substituted cinnamic acid or combinations thereof
19. The product for topical application of claim 18 wherein the hydroxy-substituted cinnamic acid is substituted at positions 2, 3, 4, 5, 6 or combinations thereof
20. The product for topical application of claim 17 wherein the phytochemical comprises maleanilic acid, homovanillic acid, folic acid, crocetin, coumaric acid, ferulic acid, sinapic acid (sinapinic acid), derivatives thereof or combinations thereof
21. The product for topical application of claim 17 wherein the phytochemical comprises cafffeic acid and the linker agent does not comprise glycerol.
22. The product for topical application of claim 1 wherein the topically acceptable agent comprises a carrier agent.
23. The product for topical application of claim 22 wherein the carrier agent bonds with at least one of X 1 or X 2 .
24. The product for topical application of claim 22 wherein the carrier agent is hydrogen, a fatty acid, a monoterpene, a diterpene, a triterpene, or combinations thereof
25. The product for topical application of claim 1 wherein the chemical composition is further characterized by the formula: C- R I C- R 2 I C- R3, wherein at least two of RI, R 2 , and R 3 are non-fatty acid carboxylates; and the other of RI, R 2 , and R 3 are each either a C 2 -C 24 fatty acid moiety, OH, or a non-fatty acid carboxylate, wherein the first and second non-fatty acid carboxylates, when present, are the same or different. WO 2008/003090 PCT/US2007/072557 22
26. The product for topical application of claim 25 wherein the first non-fatty acid carboxylate is a first phytochemical and the second non-fatty acid carboxylate is a second phytochemical, wherein the first and second phytochemical are the same or different.
27. The product for topical application of claim 25 further characterized by the formula: R4 OH R2 _" O' 0 wherein R 4 = H or OCH 3 and R 2 ,R 3 or both are non-fatty acid carboxylates comprising phytochemical.
28. A product for topical application comprising in combination a fat soluble composition comprising: a mono or diacylglycerol esterified with a plant-derived functional group comprising an aromatic species, an unsaturated isoprenoid, an unsaturated terpenoid, a hindered hydroxy-substituted cinnamic acid, an unhindered hydroxy-substituted cinnamic acid or combinations thereof, and a topically acceptable agent that is different from the fat soluble composition.
29. A product for topical application comprising in combination a fat-soluble composition, comprising: a glycerol esterified with a plant-derived functional group comprising maleanilic acid, homovanillic acid, folic acid, crocetin, coumaric acid, caffeic acid, ferulic acid, sinapic acid (sinapinic acid), derivatives thereof or combinations thereof, wherein the esterified glycerol includes at least two plant-derived functional groups, and a topically acceptable agent that is different from the fat soluble composition.
30. The product for topical application according to claim 29, wherein the two plant derived functional groups are the same.
31. The product for topical application according to claim 29, wherein the two plant derived functional groups are different. WO 2008/003090 PCT/US2007/072557 23
32. The product for topical application of claim 2 wherein the phytochemical has anti-aging properties, has anti-bacterial, has anti-viral, has anti-neoplastic properties, and has antioxidant properties or combinations thereof
33. The product for topical application of claim 7 wherein the first phytochemical absorbs primarily UVA radiation and the second phytochemical absorbs primarily UVB radiation.
34. The product for topical application of claim 1, wherein the chemical composition comprises feruloyl glyceride.
35. The product for topical application of claim 29, wherein the chemical composition comprises feruloyl glyceride.
36. The product for topical application of claim 1, wherein the product is a lotion, a sunscreen, a cosmetic product, an agrochemical, a pharmaceutical, a nutritional product or combinations thereof
37. The product for topical application of claim 29, wherein the product is a lotion, a sunscreen, a cosmetic product, an agrochemical, a pharmaceutical, a nutritional product or combinations thereof
38. A product for topical application comprising in combination a chemical composition comprising a linker agent and a compound comprising at least one UV absorbing chromophore, wherein the linker agent is characterized by the general formula: X3 X4 H -Ca-Cb-Cc-(Y)d-Ce f-H I I - XiHnl X 2 Hn 2 wherein: X 1 and X 2 are the same or different at least one of X 1 or X 2 is a functional group that bonds with the compound comprising at least one UV-absorbing chromophore, and b+f > 2; X 3 and X 4 are the same or different and X 3 , X 4 or both is a hydrophobic moiety; Y comprises an O, N, or S that is substituted or unsubstituted; each a, b, c, e and f is > 0 and a+b+c+e+f>2; d is 0 or 1; WO 2008/003090 PCT/US2007/072557 24 nl and n2 represent the number of hydrogen atoms required to complete the undesignated valencies; and m ranges from 1 to about 100 and each individual m unit may be the same or different, and a topically acceptable agent that is different from the fat soluble composition.
39. The product for topical application of claim 38 wherein the compound comprising at least one UV-absorbing chromophore comprises a phytochemical.
40. The product for topical application of claim 38 wherein X 3 , X 4 or both comprises a derivatizable naturally occurring lipid.
41. The product for topical application of claim 38 wherein the X 3 , X 4 or both comprises sphingosine, ceramide or combinations thereof
42. The product for topical application of claim 38, wherein the product is a lotion, a sunscreen, a cosmetic product, an agrochemical, a pharmaceutical, a nutritional product or combinations thereof
43. A product for topical application comprising in combination a chemical composition comprising at least two compounds having the general formula: X3 X4 H -Ca-Cb-Cc-(Y)d-Ce f-H I I - XIHnl X 2 Hn 2 wherein: X 1 and X 2 are different at least one of X 1 or X 2 is a functional group that bonds with a compound comprising at least one UV-absorbing chromophore, and b+f > 2; X 3 and X 4 are the same or different and X 3 , X 4 or both is a hydrophobic moiety; Y comprises an O, N, or S that is substituted or unsubstituted; each a, b, c, e and f is > 0 and a+b+c+e+f >2; d is 0 or 1; nI and n2 represent the number of hydrogen atoms required to complete the undesignated valencies; WO 2008/003090 PCT/US2007/072557 25 m ranges from 1 to about 100 and each individual m unit may be the same or different; and wherein the compound comprising at least one UV-absorbing chromophore comprises a phytochemical which further comprises an aromatic species, an unsaturated isoprenoid, an unsaturated terpenoid, a hindered hydroxy-substituted cinnamic acid, an unhindered hydroxy-substituted cinnamic acid or combinations thereof, and a topically acceptable agent that is different from the chemical composition comprising at least two compounds.
44. The product for topical application of claim 28, wherein the chemical composition comprises feruloyl glyceride.
45. The product for topical application of claim 28, wherein the product is a lotion, a sunscreen, a cosmetic product, an agrochemical, a pharmaceutical, a nutritional product or combinations thereof
46. The product for topical application of claim 1, wherein the amount of the chemical composition is in the range of about 3% to 10% by weight.
47. The product for topical application of claim 34, wherein the amount of feruloyl glyceride is in the range of about 3% to 10% by weight.
48. The product for topical application of claim 35, wherein the amount of the feruloyl glyceride is in the range of about 3% to 10% by weight.
49. The product for topical application of claim 28, wherein the amount of the chemical composition is in the range of about 3% to 10% by weight.
50. The product for topical application of claim 44, wherein the amount of the feruloyl glyceride is in the range of about 3% to 10% by weight.
51. The product for topical application having the compositions set forth in Example 1.
52. The product of claim 1, wherein the compositions set forth in Example 1 have approximately the same percentages by weight as set forth in Example 1.
53. The product for topical application having the compositions set forth in Example 2.
54. The product of claim 1, wherein the compositions set forth in Example 1 have approximately the same percentages by weight as set forth in Example 2.
55. The product for topical application having the compositions set forth in Example 3.
56. The product of claim 1, wherein the compositions set forth in Example 1 have approximately the same percentages by weight as set forth in Example 3.
57. The product for topical application having the compositions set forth in Example 4. WO 2008/003090 PCT/US2007/072557 26
58. The product of claim 1, wherein the compositions set forth in Example 1 have approximately the same percentages by weight as set forth in Example 4.
59. The product for topical application having the compositions set forth in Example 5.
60. The product of claim 1, wherein the compositions set forth in Example 1 have approximately the same percentages by weight as set forth in Example 5.
61. A phospholipid vitamin complex lotion wherein the amount of feruloyl glyceride is about 5% by weight.
62. A water resistant sunscreen wherein the amount of feruloyl glyceride is about 8% by weight.
63. A hair conditioner wherein the amount of feruloyl glyceride is about 3% by weight.
64. A lip protector wherein the amount of feruloyl glyceride is about 10% by weight.
65. A shave cream wherein the amount of feruloyl glyceride is about 4% by weight.
66. A fragrance product comprising a comprising a chemical composition comprising in combination a linker agent, a compound comprising at least one UV-absorbing chromophore, wherein the linker agent is characterized by the general formula: H-Ca-Cb-Cc-(Y)d-CeCf -H X1Hnl X 2 Hn 2 wherein: X 1 and X 2 are the same or different, and at least one of X 1 or X 2 is a functional group that bonds with the compound comprising at least one UV-absorbing chromophore, and b+f> 2; Y comprises an O, N, or S that is substituted or unsubstituted; each a, b, c, e and f is > 0 and a+b+c+e+f>2; d is 0 or 1; nI and n2 represent the number of hydrogen atoms required to complete the undesignated valencies; and m ranges from 1 to about 100 and each individual m unit may be the same or different, and a fragrance that is different from the linker agent or the compound comprising at least one UV-absorbing chromophore.
AU2007264975A 2006-06-29 2007-06-29 Formulations with feruloyl glycerides and methods of preparation Abandoned AU2007264975A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81753706P 2006-06-29 2006-06-29
US60/817,537 2006-06-29
PCT/US2007/072557 WO2008003090A2 (en) 2006-06-29 2007-06-29 Formulations with feruloyl glycerides and methods of preparation

Publications (1)

Publication Number Publication Date
AU2007264975A1 true AU2007264975A1 (en) 2008-01-03

Family

ID=38846582

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007264975A Abandoned AU2007264975A1 (en) 2006-06-29 2007-06-29 Formulations with feruloyl glycerides and methods of preparation

Country Status (7)

Country Link
EP (1) EP2040552A2 (en)
AU (1) AU2007264975A1 (en)
BR (1) BRPI0713966A2 (en)
CA (1) CA2656091A1 (en)
MX (1) MX2008016455A (en)
WO (1) WO2008003090A2 (en)
ZA (1) ZA200810831B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7572610B2 (en) 2005-10-03 2009-08-11 Biotechnology Research & Development Corporation Methods of making compositions comprising a UV-Absorbing chromophore
US7727514B2 (en) 2005-10-03 2010-06-01 Biotechnology Research & Development Corporation Compositions comprising a UV-absorbing chromophore
DE102011003170A1 (en) * 2010-11-10 2012-05-10 Evonik Goldschmidt Gmbh Composition containing mixtures of isostearic acid amide, glycerol ester and water
DE102014223568A1 (en) * 2014-11-19 2016-05-19 Beiersdorf Ag Preparations containing ascorbic acid, ubidecarenone and mixtures of sodium stearoylglutamate and / or cetylstearylsulfate in combination with glycerylstearate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346236B1 (en) * 2000-03-28 2002-02-12 The United States Of America As Represented By The Secretary Of Agriculture Sunscreens from vegetable oil and plant phenols
CA2448233A1 (en) * 2001-03-07 2002-09-19 The Procter & Gamble Company Topical composition comprising a three membered cyclic compound-based cosmetic bonding agent
US6890520B2 (en) * 2003-02-05 2005-05-10 Wakayama Prefecture Thermally stable ferulic acid derivatives
US7351403B2 (en) * 2003-06-17 2008-04-01 The United States Of America, As Represented By The Secretary Of Agriculture Sunscreen reagents from unsaturated waxes and triglycerides
DE602004027936D1 (en) * 2003-10-29 2010-08-12 Sonus Pharmaceutical Inc TOCOPHEROL-MODIFIED THERAPEUTIC DRUG COMPOUND

Also Published As

Publication number Publication date
BRPI0713966A2 (en) 2012-11-27
EP2040552A2 (en) 2009-04-01
ZA200810831B (en) 2009-10-28
WO2008003090A2 (en) 2008-01-03
MX2008016455A (en) 2009-05-15
CA2656091A1 (en) 2008-01-03
WO2008003090A3 (en) 2008-05-08

Similar Documents

Publication Publication Date Title
US7744856B2 (en) Formulations with feruloyl glycerides and methods of preparation
US20020146375A1 (en) Cosmetic or pharmaceutical lecithin-containing gels or low viscosity lecithin-containing O/W microemulsions
JP2001501636A (en) Gels based on cosmetic or dermatological microemulsions
JP2008513480A5 (en)
ES2663700T3 (en) Use of esters derived from natural sources with lower viscosity and higher spreading speed, as well as preparation of the natural personal care composition comprising said esters
EP4265237A1 (en) Hair care or hair cleansing or skin care or skin cleansing composition
DE10064818A1 (en) Use of chroman derivatives in cosmetic or dermatological preparations
WO2002015864A2 (en) A vehicle and concentrates for customized personal care products
AU2007264975A1 (en) Formulations with feruloyl glycerides and methods of preparation
US5731450A (en) Oil adduct conditioners
DE19518845A1 (en) Cosmetic or dermatological preparations containing phytic acid
KR20060009904A (en) Personal care compositions containing a silicone elastomer and a dispersed oil phase
JPH1025220A (en) Preparation for external use for skin
KR20160149472A (en) Hair cosmetic composition having damaged hair care effect
DE19518815A1 (en) Cosmetic or dermatological preparations containing alpha-hydroxy fatty acids
US7691397B2 (en) Ultra-stable composition comprising Moringa oil and its derivatives and uses thereof
DE19642090A1 (en) Cosmetic or dermatological gels based on microemulsions
DE19645319A1 (en) Foaming composition, useful as skin care medium e.g. as shaving foam
RU2242216C1 (en) Lifting-cream for dry and sensitive skin
Laszlo et al. DeFilippi et al.(45) Date of Patent: Jun. 29, 2010
JPH115724A (en) Cosmetic such as toilet water and nutritious lotion
JP2004352628A (en) External preparation for skin
FR3131535A1 (en) Cosmetic composition comprising a wax of vegetable origin, an oil or a butter of vegetable origin, an N acyl amino acid salt, a particular water-insoluble powder and a particular polyol.
JP2005015453A (en) Cosmetic composition containing isostearyl ferulate
Shah et al. Natural Products for Cosmeceuticals

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period